Cargando…

Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion

The recent approval by the US Food and Drug Administration of ocriplasmin for the treatment of symptomatic vitreomacular adhesion (VMA), often associated with vitreomacular traction (VMT) and macular hole (MH), has brought new attention to the field of pharmacologic vitreolysis. The need for an enzy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefanini, Francisco R, Maia, Maurício, Falabella, Paulo, Pfister, Marcel, Niemeyer, Moritz, Kashani, Amir H, Humayun, Mark S, Koss, Michael J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018320/ https://www.ncbi.nlm.nih.gov/pubmed/24851038 http://dx.doi.org/10.2147/OPTH.S32274

Ejemplares similares

Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential
por: Song, Su Jeong, et al.
Publicado: (2014)

Ocriplasmin for Treatment of Vitreomacular Traction: An Update
por: Khan, Mohammed Ali, et al.
Publicado: (2016)

Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
por: Chin, Eric K., et al.
Publicado: (2014)

OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study
por: Steel, David H. W., et al.
Publicado: (2020)

Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Bennison, Craig, et al.
Publicado: (2016)

Efficacy and Safety of Ocriplasmin Use for Vitreomacular Adhesion and Its Predictive Factors: A Systematic Review and Meta-Analysis
por: Chen, Xi, et al.
Publicado: (2022)

Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Jackson, Timothy L., et al.
Publicado: (2017)

Early vitreomacular separation with delayed macular hole closure after ocriplasmin treatment
por: Liang, I-Chia, et al.
Publicado: (2016)

Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
por: DaCosta, Joanna, et al.
Publicado: (2014)

Functional improvement assessed by multifocal electroretinogram after Ocriplasmin treatment for vitreomacular traction
por: Rossi, Settimio, et al.
Publicado: (2016)

Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment
por: Arrigo, Alessandro, et al.
Publicado: (2020)

Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
por: Katsanos, Andreas, et al.
Publicado: (2020)

PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY
por: Mein, Calvin, et al.
Publicado: (2020)

Comparison of Guided and Unguided Ocriplasmin Injection for the Treatment of Vitreomacular Traction: A Preliminary Study
por: Mastropasqua, Rodolfo, et al.
Publicado: (2016)

Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
por: Hubschman, Sasha, et al.
Publicado: (2020)

Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis
por: Furino, Claudio, et al.
Publicado: (2020)

Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature
por: Lescrauwaet, Benedicte, et al.
Publicado: (2019)

Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies
por: Joondeph, Brian C., et al.
Publicado: (2021)

Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
por: Rosati, Alessandra, et al.
Publicado: (2018)

Comparison of Reaction Response Time between Hand and Foot Controlled Devices in Simulated Microsurgical Testing
por: Pfister, Marcel, et al.
Publicado: (2014)

Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance
por: Muqit, Mahiul M. K., et al.
Publicado: (2018)

Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
por: Iuliano, Lorenzo, et al.
Publicado: (2019)

Calculating the individual probability of successful ocriplasmin treatment in eyes with vitreomacular traction–Validation and refinement of a multivariable prediction model
por: Paul, Christoph, et al.
Publicado: (2022)

ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial
por: Tadayoni, Ramin, et al.
Publicado: (2019)

Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics
por: Bertelmann, Thomas, et al.
Publicado: (2021)

Vitreomacular Traction Syndrome
por: Bottós, Juliana, et al.
Publicado: (2012)

Anti-VEGF for the Management of Diabetic Macular Edema
por: Stefanini, Francisco Rosa, et al.
Publicado: (2014)

Ocriplasmin for Vitreoretinal Diseases
por: Tsui, Irena, et al.
Publicado: (2012)

Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review
por: Schneider, Eric W, et al.
Publicado: (2011)

Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration
por: Kang, Eui Chun, et al.
Publicado: (2015)

Ocriplasmin: who is the best candidate?
por: Prospero Ponce, Claudia M, et al.
Publicado: (2016)

OCT proves that vitreomacular adhesion is significantly more likely to develop vision-threatening retinal complications than vitreomacular separation
por: Liao, Ding-Ying, et al.
Publicado: (2020)

Prevalence of vitreomacular adhesion: an optical coherence tomography analysis in the retina clinic setting
por: Reichel, Elias, et al.
Publicado: (2016)

Clinical Features of Vitreomacular Traction Syndrome with Peripheral Vitreoretinal Adhesion
por: Fukumoto, Masanori, et al.
Publicado: (2020)

Retinal breaks due to intravitreal ocriplasmin
por: Silva, Ruwan A, et al.
Publicado: (2014)

Development of a new tissue injector for subretinal transplantation of human embryonic stem cell derived retinal pigmented epithelium
por: Fernandes, Rodrigo A. Brant, et al.
Publicado: (2017)

Rhegmatogenous retinal detachment following intravitreal ocriplasmin
por: Madi, Haifa A., et al.
Publicado: (2016)

Italian real-life experience on the use of ocriplasmin
por: Barca, Francesco, et al.
Publicado: (2018)

Vitreomacular traction syndrome
por: Martins, Thiago Gonçalves dos Santos, et al.
Publicado: (2015)

Treatment of Symptomatic Vitreomacular Adhesion with Expansile Sulfur Hexafluoride (SF6) Gas
por: Buzzacco, Dominic M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a4hcekejnvgh53cdpq18tac9uj